| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |